Pregled bibliografske jedinice broj: 1118977
Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998–2007
Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998–2007 // Emerging Infectious Diseases, 17 (2011), 11; 2001-2009 doi:10.3201/eid1711.110488 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1118977 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Global Distribution and Epidemiologic Associations
of Escherichia coli Clonal Group A, 1998–2007
Autori
Johnson, James ; Menard, Megan ; Lauderdale, Tsai- Ling ; Lauderdale, Tsai-Ling ; Kosmidis, Chris ; Gordon, David ; Collignon, Peter ; Maslow, Joel ; Tambić Andrašević, Arjana ; Kuskowski, Michael
Izvornik
Emerging Infectious Diseases (1080-6040) 17
(2011), 11;
2001-2009
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Escherichia coli clonal group A (CGA)
Sažetak
Escherichia coli clonal group A (CGA) was first reported in 2001 as an emerging multidrug- resistant extraintestinal pathogen. Because CGA has considerable implications for public health, we examined the trends of its global distribution, clinical associations, and temporal prevalence for the years 1998-2007. We characterized 2, 210 E. coli extraintestinal clinical isolates from 32 centers on 6 continents by CGA status for comparison with trimethoprim/sulfamethoxazole (TMP/SMZ) phenotype, specimen type, inpatient/outpatient source, and adult/child host ; we adjusted for clustering by center. CGA prevalence varied greatly by center and continent, was strongly associated with TMP/SMZ resistance but not with other epidemiologic variables, and exhibited no temporal prevalence trend. Our findings indicate that CGA is a prominent, primarily TMP/SMZ-resistant extraintestinal pathogen concentrated within the Western world, with considerable pathogenic versatility. The stable prevalence of CGA over time suggests full emergence by the late 1990s, followed by variable endemicity worldwide as an antimicrobial drug- resistant public health threat.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE